← Leaderboards
Gianfranco Arroyo
Universidad Peruana Cayetano Heredia
$673,816
Attributed
$673,816
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $134.9K · FY2019–23$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$673,816 · 1
By mechanism
R01$673,816 · 1
Top collaborators
No co-investigators on record.
Most similar at Universidad Peruana Cayetano Heredia
Same institution · by research overlap
- Hector Hugo Garcia$15,933,000
- Manuela Renee Verastegui$1,378,374
- Javier A Bustos$2,011,690
- Joseph Raymond Zunt$11,635,157
- Saul J Santivanez$675,000
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisDoseAcuteAnimal ModelAdrenal Cortex HormonesDexamethasoneAlbendazoleAnti-Inflammatory AgentsAntiinflammatory EffectAntimetabolitesAppropriate DoseAnimalsAnthelminticsBrainBrain EdemaBrain TissueCentral Nervous System CystsClinical PracticeClinical ResearchControlled StudyCystDeteriorationDeveloped CountriesEarly Treatment
Grant awards (5)
Alternative therapeutic approaches for the control of brain inflammation secondary to antihelminthic therapy in neurocysticercosis using a novel experimental pig model$134,720
R01 · FY2023 · AI · contact PI
Alternative therapeutic approaches for the control of brain inflammation secondary to antihelminthic therapy in neurocysticercosis using a novel experimental pig model$134,720
R01 · FY2022 · AI · contact PI
Alternative therapeutic approaches for the control of brain inflammation secondary to antihelminthic therapy in neurocysticercosis using a novel experimental pig model$134,720
R01 · FY2021 · AI · contact PI
Alternative therapeutic approaches for the control of brain inflammation secondary to antihelminthic therapy in neurocysticercosis using a novel experimental pig model$134,720
R01 · FY2020 · AI · contact PI
Alternative therapeutic approaches for the control of brain inflammation secondary to antihelminthic therapy in neurocysticercosis using a novel experimental pig model$134,936
R01 · FY2019 · AI · contact PI